BioPharmaDispatch spoke with Viatris' Sylvain Vigneault and Stephen Jenkins about how the company's program for STEM students is one component of a wider strategic initiative aimed at growing the company's industrial capacity in Australia.
Viatris says its STEM workforce is critical to fulfilling its potential
December 6, 2022 Latest NewsBioPharmaLatest Video
New Stories
-
'Found irregularities and anomalies in the instruments of delegation from the minister'
December 20, 2024 - - Latest News -
FDA approves Mesoblast's cell therapy to treat steroid-refractory acute graft-versus-host disease
December 19, 2024 - - Australian Biotech -
Wholesalers secure five-year agreement with the Government
December 19, 2024 - - Latest News -
When the Government funds a health technology, the community makes certain assumptions
December 19, 2024 - - Latest News -
If this decision to undermine the TGA reflects a policy decision, be transparent about it
December 18, 2024 - - Latest News -
Race Oncology appoints Opthea founder to its board
December 18, 2024 - - Australian Biotech -
New listings and higher prescription volumes driving PBS spend
December 18, 2024 - - Latest News